Another example of effective gene silencing was put forward by Vinhas et al. that combined gene silencing via a AuNP loaded with an ASO targeting BCR-ABL1 and imatinib, enhancing cell death in chronic myeloid leukemia (CML) cells [141]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.